On 23 December 2020, Members of the European Parliament (MEPs): Adriana Maldonado López (S&D) and Idoia Villanueva Ruiz (The Left), posed a written parliamentary question to the European Commission: “Last
Category: EU Q&A
Requirements to be met to secure acceptance of a negative COVID-19 test in some Member States
On 12 October 2020, Spanish Member of the European Parliament (MEP) Izaskun Bilbao Barandica of the Renew Europe Group, posed a written parliamentary question to the European Commission: “Throughout the
Renegotiating with Gilead Sciences in view of the WHO Solidarity trial result
On 11 November 2020, Belgian Member of the European Parliament (MEP) Marc Botenga of The Left group in the European Parliament – GUE/NGL, posed a written parliamentary question to the
Investment in Portugal’s National Health Service (SNS)
On 12 November 2020, Portuguese Member of the European Parliament (MEP) Sandra Pereira of The Left group in the European Parliament – GUE/NGL, posed a written parliamentary question to the
Price-setting mechanisms for remdesivir as part of the purchase or procurement contracts between the Commission and Gilead Sciences
On 11 November 2020, Belgian Member of the European Parliament (MEP) Marc Botenga of The Left group in the European Parliament – GUE/NGL, posed a written parliamentary question to the
Preliminary contracts with vaccine manufacturers
On 18 November 2020, German Member of the European Parliament (MEP) Markus Buchheit of the Identity and Democracy Group, posed a written parliamentary question to the European Commission: “As part